GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » Cyclically Adjusted FCF per Share

Meta Biomed Co (XKRX:059210) Cyclically Adjusted FCF per Share : ₩-126.94 (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Meta Biomed Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩-7.679. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-126.94 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Meta Biomed Co was 22.40% per year. The lowest was -18.30% per year. And the median was 11.75% per year.

As of today (2025-05-31), Meta Biomed Co's current stock price is ₩5890.00. Meta Biomed Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩-126.94. Meta Biomed Co's Cyclically Adjusted Price-to-FCF of today is .


Meta Biomed Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Meta Biomed Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co Cyclically Adjusted FCF per Share Chart

Meta Biomed Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -286.39 -183.36 -206.76 -201.30 -123.20

Meta Biomed Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -209.24 -195.36 -168.60 -123.20 -126.94

Competitive Comparison of Meta Biomed Co's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Meta Biomed Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meta Biomed Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Meta Biomed Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Meta Biomed Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Meta Biomed Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Meta Biomed Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-7.679/122.5900*122.5900
=-7.679

Current CPI (Mar. 2025) = 122.5900.

Meta Biomed Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -1.461 100.051 -1.790
201509 -82.653 100.111 -101.212
201512 -24.755 100.220 -30.280
201603 -112.993 100.561 -137.746
201606 14.880 100.791 18.098
201609 90.782 101.461 109.687
201612 -39.141 101.561 -47.245
201703 -51.052 102.851 -60.850
201706 60.374 102.611 72.129
201709 -127.527 103.491 -151.063
201712 -356.675 102.991 -424.550
201803 -446.681 104.101 -526.015
201806 869.849 104.130 1,024.051
201809 -1,121.497 105.651 -1,301.313
201812 -5.123 104.351 -6.018
201903 -40.153 104.491 -47.108
201906 -72.972 104.881 -85.293
201909 -102.681 105.200 -119.654
201912 -8.806 105.121 -10.269
202003 -44.792 105.354 -52.120
202006 -26.117 105.112 -30.460
202009 88.830 106.198 102.542
202012 48.403 105.765 56.103
202103 -51.694 107.357 -59.029
202106 149.945 107.579 170.868
202109 166.243 108.759 187.384
202112 140.741 109.676 157.312
202203 77.587 111.848 85.039
202206 -122.360 114.072 -131.497
202209 -42.284 114.715 -45.187
202212 -186.531 115.179 -198.533
202303 -179.945 116.507 -189.340
202306 -35.532 117.182 -37.172
202309 125.478 118.964 129.303
202312 30.213 118.837 31.167
202403 -120.559 120.123 -123.035
202406 114.988 120.007 117.463
202409 108.146 120.861 109.693
202412 280.801 121.135 284.173
202503 -7.679 122.590 -7.679

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Meta Biomed Co  (XKRX:059210) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Meta Biomed Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co Business Description

Traded in Other Exchanges
N/A
Address
270, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co Headlines

No Headlines